{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,26]],"date-time":"2026-07-26T01:57:54Z","timestamp":1785031074847,"version":"3.55.0"},"reference-count":52,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,31]],"date-time":"2025-01-31T00:00:00Z","timestamp":1738281600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004826","name":"Beijing Natural Science Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004826","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002367","name":"Chinese Academy of Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002367","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cell Reports Medicine"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1016\/j.xcrm.2025.101984","type":"journal-article","created":{"date-parts":[[2025,2,27]],"date-time":"2025-02-27T15:33:37Z","timestamp":1740670417000},"page":"101984","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Selective apoptosis of tumor-associated platelets boosts the anti-metastatic potency of PD-1 blockade therapy"],"prefix":"10.1016","volume":"6","author":[{"given":"Suying","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhouliang","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zefang","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feilong","family":"Qi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianjiao","family":"Chu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bozhao","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuliang","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5040-9793","authenticated-orcid":false,"given":"Guangjun","family":"Nie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0294-8861","authenticated-orcid":false,"given":"Suping","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.xcrm.2025.101984_bib1","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","article-title":"Hallmarks of Cancer: The Next Generation","volume":"144","author":"Hanahan","year":"2011","journal-title":"Cell"},{"key":"10.1016\/j.xcrm.2025.101984_bib2","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1038\/nm730","article-title":"Tumor-associated B7-H1 promotes T-cell apoptosis: A potential mechanism of immune evasion","volume":"8","author":"Dong","year":"2002","journal-title":"Nat. Med."},{"key":"10.1016\/j.xcrm.2025.101984_bib3","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1084\/jem.192.7.1027","article-title":"Engagement of the PD-1 immunoinhibitory receptor by a novel B7 family member leads to negative regulation of lymphocyte activation","volume":"192","author":"Freeman","year":"2000","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.xcrm.2025.101984_bib4","doi-asserted-by":"crossref","first-page":"12293","DOI":"10.1073\/pnas.192461099","article-title":"Involvement of PD-L1 on tumor cells in the escape from host immune system and tumor immunotherapy by PD-L1 blockade","volume":"99","author":"Iwai","year":"2002","journal-title":"Proc. Natl.\u00a0Acad. Sci. USA"},{"key":"10.1016\/j.xcrm.2025.101984_bib5","doi-asserted-by":"crossref","first-page":"5309","DOI":"10.1016\/j.cell.2021.09.020","article-title":"Hallmarks of response, resistance, and toxicity to immune checkpoint blockade","volume":"184","author":"Morad","year":"2021","journal-title":"Cell"},{"key":"10.1016\/j.xcrm.2025.101984_bib6","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1038\/nrc2622","article-title":"Metastasis: from dissemination to organ-specific colonization","volume":"9","author":"Nguyen","year":"2009","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.xcrm.2025.101984_bib7","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1038\/nrc3004","article-title":"Contribution of platelets to tumour metastasis","volume":"11","author":"Gay","year":"2011","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.xcrm.2025.101984_bib8","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1016\/j.ccell.2018.03.002","article-title":"The Platelet Lifeline to Cancer: Challenges and Opportunities","volume":"33","author":"Haemmerle","year":"2018","journal-title":"Cancer Cell"},{"key":"10.1016\/j.xcrm.2025.101984_bib9","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1038\/s41568-023-00639-6","article-title":"The dynamic role of platelets in cancer progression and their therapeutic implications","volume":"24","author":"Li","year":"2024","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.xcrm.2025.101984_bib10","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1038\/s41419-019-1367-x","article-title":"Cancer cell-derived immunoglobulin G activates platelets by binding to platelet Fc\u03b3RIIa","volume":"10","author":"Miao","year":"2019","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.xcrm.2025.101984_bib11","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1182\/blood-2017-05-743187","article-title":"Cancer and platelet crosstalk: opportunities and challenges for aspirin and other antiplatelet agents","volume":"131","author":"Xu","year":"2018","journal-title":"Blood"},{"key":"10.1016\/j.xcrm.2025.101984_bib12","doi-asserted-by":"crossref","first-page":"2359","DOI":"10.1182\/blood-2018-12-852830","article-title":"Tumor-educated platelets","volume":"133","author":"t Veld","year":"2019","journal-title":"Blood"},{"key":"10.1016\/j.xcrm.2025.101984_bib13","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1007\/s00262-020-02758-7","article-title":"Inflammatory cell-associated tumors. Not only macrophages (TAMs), fibroblasts (TAFs) and neutrophils (TANs) can infiltrate the tumor microenvironment. The unique role of tumor associated platelets (TAPs)","volume":"70","author":"Dymicka-Piekarska","year":"2020","journal-title":"Cancer Immunol. Immunother."},{"key":"10.1016\/j.xcrm.2025.101984_bib14","doi-asserted-by":"crossref","first-page":"E3053","DOI":"10.1073\/pnas.1411082111","article-title":"Platelets guide the formation of early metastatic niches","volume":"111","author":"Labelle","year":"2014","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.xcrm.2025.101984_bib15","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/BF00116627","article-title":"Tumor cell-platelet interactions in\u00a0vitro and their relationship to in\u00a0vivo arrest of hematogenously circulating tumor\u00a0cells","volume":"5","author":"Menter","year":"1987","journal-title":"Clin. Exp. Metastasis"},{"key":"10.1016\/j.xcrm.2025.101984_bib16","doi-asserted-by":"crossref","first-page":"9325","DOI":"10.1073\/pnas.95.16.9325","article-title":"P-selectin deficiency attenuates tumor growth and metastasis","volume":"95","author":"Kim","year":"1998","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.xcrm.2025.101984_bib17","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1182\/blood.V96.5.1789","article-title":"Immobilized platelets support human colon carcinoma cell tethering, rolling, and firm adhesion under dynamic flow conditions","volume":"96","author":"McCarty","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.xcrm.2025.101984_bib18","first-page":"1295","article-title":"Lysis of tumor cells by natural killer cells in mice is impeded by platelets","volume":"59","author":"Nieswandt","year":"1999","journal-title":"Cancer Res."},{"key":"10.1016\/j.xcrm.2025.101984_bib19","first-page":"1713","article-title":"Protection from tumor necrosis factor-mediated cytolysis by platelets","volume":"143","author":"Philippe","year":"1993","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.xcrm.2025.101984_bib20","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1158\/0008-5472.CAN-11-1872","article-title":"Platelet-Derived MHC Class I Confers a Pseudonormal Phenotype to Cancer Cells That Subverts the Antitumor Reactivity of Natural Killer Immune Cells","volume":"72","author":"Placke","year":"2012","journal-title":"Cancer Res."},{"key":"10.1016\/j.xcrm.2025.101984_bib21","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1016\/j.ccr.2011.09.009","article-title":"Direct Signaling between Platelets and Cancer Cells Induces an Epithelial-Mesenchymal-Like Transition and Promotes Metastasis","volume":"20","author":"Labelle","year":"2011","journal-title":"Cancer Cell"},{"key":"10.1016\/j.xcrm.2025.101984_bib22","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.ccr.2013.05.008","article-title":"Platelet-Derived Nucleotides Promote Tumor-Cell Transendothelial Migration and Metastasis via P2Y2 Receptor","volume":"24","author":"Schumacher","year":"2013","journal-title":"Cancer Cell"},{"key":"10.1016\/j.xcrm.2025.101984_bib23","doi-asserted-by":"crossref","first-page":"2036","DOI":"10.1158\/1541-7786.MCR-21-0383","article-title":"Platelet-Coated Circulating Tumor Cells Are a Predictive Biomarker in Patients with Metastatic Castrate-Resistant Prostate Cancer","volume":"19","author":"Chai","year":"2021","journal-title":"Mol. Cancer Res."},{"key":"10.1016\/j.xcrm.2025.101984_bib24","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.3892\/ol.2020.11722","article-title":"Extravasated platelet aggregation contributes to tumor progression via the accumulation of myeloid-derived suppressor cells in gastric cancer with peritoneal metastasis","volume":"20","author":"Yamaguchi","year":"2020","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.xcrm.2025.101984_bib25","doi-asserted-by":"crossref","first-page":"3030","DOI":"10.1182\/blood-2012-05-427799","article-title":"Elevated serum soluble CD40 ligand in cancer patients may play an immunosuppressive role","volume":"120","author":"Huang","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.xcrm.2025.101984_bib26","doi-asserted-by":"crossref","first-page":"2703","DOI":"10.1182\/blood-2008-02-142422","article-title":"High plasma levels of soluble P-selectin are predictive of venous thromboembolism in cancer patients: results from the Vienna Cancer and Thrombosis Study (CATS)","volume":"112","author":"Ay","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.xcrm.2025.101984_bib27","doi-asserted-by":"crossref","DOI":"10.34133\/research.0236","article-title":"Desialylated Platelet Clearance in the Liver is a Novel Mechanism of Systemic Immunosuppression","volume":"6","author":"Li","year":"2023","journal-title":"Research"},{"key":"10.1016\/j.xcrm.2025.101984_bib28","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1080\/10408363.2016.1200008","article-title":"Platelets are versatile cells: New discoveries in hemostasis, thrombosis, immune responses, tumor metastasis and beyond","volume":"53","author":"Xu","year":"2016","journal-title":"Crit. Rev. Clin. Lab Sci."},{"key":"10.1016\/j.xcrm.2025.101984_bib29","doi-asserted-by":"crossref","first-page":"7145","DOI":"10.1182\/blood-2011-03-344812","article-title":"BCL2\/BCL-XL inhibition induces apoptosis, disrupts cellular calcium homeostasis, and prevents platelet activation","volume":"117","author":"Vogler","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.xcrm.2025.101984_bib30","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1186\/s12885-018-4584-2","article-title":"Chloroquine reduces hypercoagulability in pancreatic cancer through inhibition of neutrophil extracellular traps","volume":"18","author":"Boone","year":"2018","journal-title":"BMC Cancer"},{"key":"10.1016\/j.xcrm.2025.101984_bib31","doi-asserted-by":"crossref","first-page":"5256","DOI":"10.1038\/ncomms6256","article-title":"Platelets promote tumour metastasis via interaction between TLR4 and tumour cell-released high-mobility group box1 protein","volume":"5","author":"Yu","year":"2014","journal-title":"Nat. Commun."},{"key":"10.1016\/j.xcrm.2025.101984_bib32","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1021\/jm00027a001","article-title":"Design and synthesis of novel cyclic RGD-containing peptides as highly potent and selective integrin .alpha.IIb.beta.3 antagonists","volume":"37","author":"Cheng","year":"1994","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.xcrm.2025.101984_bib33","doi-asserted-by":"crossref","first-page":"3570","DOI":"10.1182\/blood-2002-02-0641","article-title":"Specific inhibition of P-selectin-mediated cell adhesion by phage display-derived peptide antagonists","volume":"100","author":"Molenaar","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.xcrm.2025.101984_bib34","first-page":"541","article-title":"Human tumor cells cultured \"in\u00a0vitro\" activate platelet function by producing ADP or thrombin","volume":"74","author":"Zucchella","year":"1989","journal-title":"Haematologica"},{"key":"10.1016\/j.xcrm.2025.101984_bib35","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.1172\/JCI85086","article-title":"FAK regulates platelet extravasation and tumor growth after antiangiogenic therapy withdrawal","volume":"126","author":"Haemmerle","year":"2016","journal-title":"J.\u00a0Clin. Investig."},{"key":"10.1016\/j.xcrm.2025.101984_bib36","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.ejphar.2008.04.063","article-title":"Inhibition of \u03b14 integrin mediated adhesion was involved in the reduction of B16-F10 melanoma cells lung colonization in C57BL\/6 mice treated with gambogic acid","volume":"589","author":"Zhao","year":"2008","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.xcrm.2025.101984_bib37","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1038\/onc.2009.408","article-title":"JWA regulates melanoma metastasis by integrin alphaVbeta3 signaling","volume":"29","author":"Bai","year":"2010","journal-title":"Oncogene"},{"key":"10.1016\/j.xcrm.2025.101984_bib38","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1158\/1078-0432.CCR-11-1166","article-title":"Modulation of NOXA and MCL-1 as a strategy for sensitizing melanoma cells to the BH3-mimetic ABT-737","volume":"18","author":"Lucas","year":"2012","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.xcrm.2025.101984_bib39","doi-asserted-by":"crossref","first-page":"3174","DOI":"10.1182\/blood.2019003976","article-title":"Lessons to learn from tumor-educated platelets","volume":"137","author":"Roweth","year":"2021","journal-title":"Blood"},{"key":"10.1016\/j.xcrm.2025.101984_bib40","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1038\/s41568-021-00413-6","article-title":"Overcoming TGF\u03b2-mediated immune evasion in cancer","volume":"22","author":"Tauriello","year":"2022","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.xcrm.2025.101984_bib41","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.ccr.2005.10.012","article-title":"TGF-\u03b2 directly targets cytotoxic T\u00a0cell functions during tumor evasion of immune surveillance","volume":"8","author":"Thomas","year":"2005","journal-title":"Cancer Cell"},{"key":"10.1016\/j.xcrm.2025.101984_bib42","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1007\/s00262-004-0652-3","article-title":"Transforming growth factor-\u03b21 immobilises dendritic cells within skin tumours and facilitates tumour escape from the immune system","volume":"54","author":"Weber","year":"2005","journal-title":"Cancer Immunol. Immunother."},{"key":"10.1016\/j.xcrm.2025.101984_bib43","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.aai7911","article-title":"Platelets subvert T\u00a0cell immunity against cancer via GARP-TGF\u03b2 axis","volume":"2","author":"Rachidi","year":"2017","journal-title":"Sci. Immunol."},{"key":"10.1016\/j.xcrm.2025.101984_bib44","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1038\/s41577-019-0218-4","article-title":"Tumour-intrinsic resistance to immune checkpoint blockade","volume":"20","author":"Kalbasi","year":"2020","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.xcrm.2025.101984_bib45","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1038\/s41392-023-01522-4","article-title":"Immune checkpoint therapy for solid tumours: clinical dilemmas and future trends","volume":"8","author":"Sun","year":"2023","journal-title":"Signal Transduct. Targeted Ther."},{"key":"10.1016\/j.xcrm.2025.101984_bib46","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1161\/CIRCRESAHA.123.323662","article-title":"Thrombocytopenia Independently Leads to Changes in Monocyte Immune Function","volume":"134","author":"Li","year":"2024","journal-title":"Circ. Res."},{"key":"10.1016\/j.xcrm.2025.101984_bib47","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.thromres.2008.05.003","article-title":"Strategies for antiplatelet targets and agents","volume":"123","author":"Xiang","year":"2008","journal-title":"Thromb. Res."},{"key":"10.1016\/j.xcrm.2025.101984_bib48","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1038\/s41573-021-00155-y","article-title":"Beyond immune checkpoint blockade: emerging immunological strategies","volume":"20","author":"Kubli","year":"2021","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.xcrm.2025.101984_bib49","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1038\/s41392-020-00449-4","article-title":"Advantages of targeting the tumor immune microenvironment over blocking immune checkpoint in cancer immunotherapy","volume":"6","author":"Tang","year":"2021","journal-title":"Signal Transduct. Targeted Ther."},{"key":"10.1016\/j.xcrm.2025.101984_bib50","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1038\/s41591-018-0014-x","article-title":"Understanding the tumor immune microenvironment (TIME) for effective therapy","volume":"24","author":"Binnewies","year":"2018","journal-title":"Nat. Med."},{"key":"10.1016\/j.xcrm.2025.101984_bib51","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/j.ccr.2005.05.024","article-title":"Therapeutic targeting of the tumor microenvironment","volume":"7","author":"Joyce","year":"2005","journal-title":"Cancer Cell"},{"key":"10.1016\/j.xcrm.2025.101984_bib52","series-title":"Metastasis. Methods in Molecular Biology","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/978-1-0716-1350-4_4","article-title":"Patient-Derived Xenografts from Solid Tumors (PDX) for Models of Metastasis","author":"Wulf-Goldenberg","year":"2021"}],"container-title":["Cell Reports Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666379125000576?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666379125000576?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,20]],"date-time":"2025-03-20T06:49:05Z","timestamp":1742453345000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666379125000576"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":52,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,3]]}},"alternative-id":["S2666379125000576"],"URL":"https:\/\/doi.org\/10.1016\/j.xcrm.2025.101984","relation":{},"ISSN":["2666-3791"],"issn-type":[{"value":"2666-3791","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Selective apoptosis of tumor-associated platelets boosts the anti-metastatic potency of PD-1 blockade therapy","name":"articletitle","label":"Article Title"},{"value":"Cell Reports Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xcrm.2025.101984","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"101984"}}